Ethris Alternatives & Competitors
12 companies similar to Ethris — Clinical stage biotech company focused on development of disruptive mRNA therape...
Modalis Therapeutics
Modalis is an emerging biotech company that develops therapeutics using CRISPR based techn...
Cambridge, United States
SonoThera
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
South San Francisco, Unit...
Reforgene Medicine
Innovation for Life
Guangzhou, China
Carbon Biosciences
Expanding Therapeutic Potential with Novel Parvovirus Gene Therapy
Boston, United States
Track all Ethris competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Shape Therapeutics Inc.
The future of programmable RNA Medicines
Seattle, United States
Arbor Biotechnologies
Genetic medicines for genetic diseases
Cambridge, United States
Beam Therapeutics
Our vision is to provide life-long cures for patients suffering from serious diseases.
Cambridge, United States
Pneuma Respiratory, Inc.
Our mission is to treat the world’s largest preventable cause of death – smoking.
Boone, United States
Libra Therapeutics
Restoring Cellular Balance: Developing novel therapeutics for neurodegenerative disease
San Diego, United States
Ensoma
The future of medicine lies within us.
Boston, United States
GENETiKS GLOBAL - Genetic Diagnostic Center and Laboratories
The science we need to transfer health from generation to generation: Genetics
Istanbul, Turkey
About Ethris
Clinical stage biotech company focused on development of disruptive mRNA therapeutics for severe respiratory diseases
Development of mRNA therapeutics, Innovative RNA delivery platforms, Collaborative partnerships and licensing, Clinical pipeline advancement
Pharmaceutical companies, Biotech firms, Healthcare providers, Patients with respiratory and genetic disorders
Messenger RNA Technology, Therapeutic Proteins, Transcript Therapies, Integrated Platform, Gene Therapy, Drug Development, Cell Therapy, Tissue Engineering, Biopharmaceuticals
B2B, B2C, B2B2C
Licensing, Project Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Ethris and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Ethris on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.